Treatment of Myelofibrosis and Other MPNs: Best Practices and Future Directions
Among the Philadelphia-negative myeloproliferative neoplasms (MPNs), polycythemia vera (PV) and essential thrombocythemia (ET) have a higher rate of incidence compared to myelofibrosis (MF); however, MF is associated with worse clinical outcomes. Significant clinical challenges remain with MPNs and increased awareness of best practices can help clinicians manage MPNs during treatment selection and remediate treatment-emergent side effects.
Inclusion of emerging treatment approaches must be considered during the initial treatment planning process. Treatment of Myelofibrosis and Other MPNs: Best Practices and Future Directions will discuss guidelines that support consistent decision-making for appropriate treatment of MPNs, including considerations for the management of cytopenias and other possible complications. The activity will increase awareness of emerging clinical-study data and explore the potential to optimize treatments via patient referrals to recruiting clinical trials.
- Apply current guidelines and evidence to make appropriate management choices for patients with myelofibrosis and other MPNs
- Evaluate efficacy and safety data on emerging treatment approaches for myelofibrosis and other MPNs
- Communicate clearly with patients to ensure a shared understanding of symptoms, treatment goals, and potential benefits of therapy for myelofibrosis and other MPNs
This activity is intended for hematologists, oncologists, and other members of the oncology care team involved in the care of patients with MPNs.
Physicians: The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Nurses: Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Physicians: The Potomac Center for Medical Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about the CME accreditation of this program, please email: email@example.com.
Nurses: This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
For information about the CNE accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.
Jane L. Liesveld, MD
Professor of Medicine
Wilmot Cancer Institute
University of Rochester
Srdan Verstovsek, MD, PhD
United Energy Resources, Inc.
Professor of Medicine
Director, Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms
Department of Leukemia
MD Anderson Cancer Center
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control content of a continuing medical education program provided by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards of Commercial Support in advance of delivery of the activity to learners.
Disclosures will be made known to the participants prior to the activity.
The content of this activity was vetted by an external reviewer to assure objectivity and that the activity is free of commercial bias.
Event staff will be glad to assist you with any specials needs (e.g. physical, dietary, etc.). Please email email@example.com at least 5 days prior to the program.
Provided by the Potomac Center for Medical Education
Jointly provided by Global Education Group and Rockpointe Oncology
This activity is supported by an educational grant from Celgene Corporation and Incyte.